017810 — Pulmuone Corporate Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapNeutral

Market Cap
KR₩544bn
Enterprise Value
KR₩2tn
Revenue
KR₩3tn

Annual income statement for Pulmuone Corporate, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,311,200	2,518,896	2,838,304	2,993,468	3,213,697
Cost of Revenue
Gross Profit	611,494	656,235	700,419	759,041	814,475
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	2,270,427	2,492,007	2,813,313	2,940,415	3,130,788
Operating Profit	40,773	26,890	24,991	53,053	82,909
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	17,955	13,509	-18,413	14,312	40,970
Provision for Income Taxes
Net Income After Taxes	11,834	304	-36,967	13,358	34,387
Minority Interest
Net Income Before Extraordinary Items
Net Income	16,280	13,357	-18,602	19,516	35,403
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	16,280	5,326	-29,957	9,365	25,035
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	503	304	-803	526	718
Dividends per Share